4OR.F - Organovo Holdings, Inc.

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
3/31/2019
3/31/2018
3/31/2017
3/31/2016
Total Revenue
3,357
3,091
4,603
4,230
1,483
Cost of Revenue
552
482
1,030
956
-
Gross Profit
2,805
2,609
3,573
3,274
-
Operating Expenses
Research Development
13,454
14,752
17,956
19,545
18,008
Selling General and Administrative
16,529
15,131
20,888
22,304
22,118
Total Operating Expenses
29,841
29,883
38,844
41,849
40,126
Operating Income or Loss
-27,036
-27,274
-35,271
-38,575
-38,643
Interest Expense
-
-
-
0
0
Total Other Income/Expenses Net
288
-63
-8
-47
-17
Income Before Tax
-25,997
-26,632
-34,801
-38,424
-38,572
Income Tax Expense
2
3
2
23
3
Income from Continuing Operations
-25,999
-26,635
-34,803
-38,447
-38,575
Net Income
-25,999
-26,635
-34,803
-38,447
-38,575
Net Income available to common shareholders
-25,999
-26,635
-34,803
-38,447
-38,575
Reported EPS
Basic
-
-0.23
-0.32
-0.39
-0.42
Diluted
-
-0.23
-0.32
-0.39
-0.42
Weighted average shares outstanding
Basic
-
115,380
107,244
97,763
92,392
Diluted
-
115,380
107,244
97,763
92,392
EBITDA
-
-26,294
-34,004
-37,275
-37,757